Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
Boston ScientificBSX |
-$1.68B |
 |
MedtronicMDT |
-$87M |
 |
Intuitive SurgicalISRG |
-$1.2B |
 |
ConmedCNMD |
-$2.6M |
 |
RxSightRXST |
$8.7M |
Are Edwards Lifesciences Insiders Buying or Selling?
Edwards Lifesciences (EW) has had 11 insider transactions in the past 90 days, all sells. The most recent was Daniel Lippis, who sold 619 shares at $85.65 on October 8, 2026.
Insider trading patterns can signal confidence or concern from the people who know the company best. AltIndex tracks insider transactions as one of 25+ alternative data signals in the EW AI Score. For government officials trading this stock, see EW congressional trading.
Who’s Trading Edwards Lifesciences Stock?
| Insider | Activity | Trades | Last Trade |
|---|---|---|---|
| BOBO DONALD E JR | Sold $14M | 20 | May 27, 2026 |
| Bernard Zovighian | Sold $9.2M | 12 | Jul 27, 2026 |
| Scott Ullem | Sold $8M | 13 | Apr 9, 2026 |
| Daveen Chopra | Sold $3.6M | 7 | Aug 26, 2026 |
| Larry Wood | Sold $3M | 3 | Aug 18, 2025 |
| Daniel Lippis | Sold $1.5M | 20 | Oct 8, 2026 |
Recent Edwards Lifesciences Insider Transactions
| Insider | Transaction Date | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Daniel Lippis | Oct 8, 2026 | Sell | 619 | $85.65 | $53,000 |
| Daniel Lippis | Sep 11, 2026 | Sell | 619 | $87.51 | $54,000 |
| Andrew Dahl | Aug 31, 2026 | Sell | 544 | $91.06 | $50,000 |
| Annette Bruls | Aug 28, 2026 | Sell | 2,644 | $89.98 | $240,000 |
| Daveen Chopra | Aug 26, 2026 | Sell | 30,646 | $90.99 | $2.8M |
| Daveen Chopra | Aug 26, 2026 | Sell | 1,154 | $91.76 | $110,000 |
| Wayne Markowitz | Aug 26, 2026 | Sell | 1,240 | $91.47 | $110,000 |
| Daniel Lippis | Aug 11, 2026 | Sell | 619 | $92.03 | $57,000 |
| Wayne Markowitz | Jul 30, 2026 | Sell | 146 | $86.03 | $13,000 |
| Wayne Markowitz | Jul 28, 2026 | Sell | 9,628 | $85.06 | $820,000 |
| Bernard Zovighian | Jul 27, 2026 | Sell | 2,921 | $83.93 | $250,000 |
| Daniel Lippis | Jul 10, 2026 | Sell | 619 | $91.7 | $57,000 |
| Bernard Zovighian | Jun 17, 2026 | Sell | 523 | $87.92 | $46,000 |
| Andrew Dahl | May 29, 2026 | Sell | 568 | $86.08 | $49,000 |
| BOBO DONALD E JR | May 27, 2026 | Sell | 23,145 | $86.42 | $2M |
| Daveen Chopra | May 22, 2026 | Sell | 1,500 | $84.6 | $130,000 |
| Daniel Lippis | May 18, 2026 | Sell | 620 | $81.14 | $50,000 |
| BOBO DONALD E JR | May 15, 2026 | Sell | 9,968 | $82.07 | $820,000 |
| BOBO DONALD E JR | May 15, 2026 | Sell | 8,000 | $81.82 | $650,000 |
| Bernard Zovighian | May 12, 2026 | Sell | 35,506 | $77.92 | $2.8M |
| Bernard Zovighian | May 12, 2026 | Sell | 845 | $78.4 | $66,000 |
| Wayne Markowitz | May 11, 2026 | Sell | 593 | $79.73 | $47,000 |
| Daniel Lippis | May 4, 2026 | Sell | 1,019 | $83.98 | $86,000 |
| Daniel Lippis | May 1, 2026 | Sell | 1,000 | $82.99 | $83,000 |
| Daniel Lippis | May 1, 2026 | Sell | 19 | $83.99 | $1,600 |
| Scott Ullem | Apr 9, 2026 | Sell | 8,324 | $79.79 | $660,000 |
| Scott Ullem | Apr 9, 2026 | Sell | 4,676 | $80.5 | $380,000 |
| Daniel Lippis | Apr 6, 2026 | Sell | 1,019 | $80.98 | $83,000 |
| BOBO DONALD E JR | Apr 2, 2026 | Sell | 18,004 | $80.05 | $1.4M |
| BOBO DONALD E JR | Apr 2, 2026 | Sell | 4,676 | $80.59 | $380,000 |
| Scott Ullem | Mar 11, 2026 | Sell | 7,901 | $85.21 | $670,000 |
| Scott Ullem | Mar 11, 2026 | Sell | 5,099 | $84.46 | $430,000 |
| Daniel Lippis | Mar 11, 2026 | Sell | 1,019 | $85.38 | $87,000 |
| BOBO DONALD E JR | Mar 2, 2026 | Sell | 11,340 | $85.93 | $970,000 |
| BOBO DONALD E JR | Feb 25, 2026 | Sell | 24,000 | $83.84 | $2M |
| Bernard Zovighian | Feb 12, 2026 | Sell | 19,898 | $76.61 | $1.5M |
| Bernard Zovighian | Feb 12, 2026 | Sell | 2,532 | $77.13 | $200,000 |
| Daniel Lippis | Jan 9, 2026 | Sell | 1,019 | $85.7 | $87,000 |
| BOBO DONALD E JR | Jan 6, 2026 | Sell | 8,708 | $85.98 | $750,000 |
| BOBO DONALD E JR | Jan 6, 2026 | Sell | 2,632 | $84.62 | $220,000 |
| BOBO DONALD E JR | Dec 12, 2025 | Sell | 5,900 | $83.74 | $490,000 |
| BOBO DONALD E JR | Dec 12, 2025 | Sell | 5,486 | $83.79 | $460,000 |
| Daniel Lippis | Dec 12, 2025 | Sell | 1,019 | $84.03 | $86,000 |
| STONE HEISZ LESLIE | Dec 12, 2025 | Sell | 2,615 | $83.41 | $220,000 |
| Daveen Chopra | Dec 11, 2025 | Sell | 2,000 | $84.38 | $170,000 |
| BOBO DONALD E JR | Dec 10, 2025 | Sell | 11,340 | $83.83 | $950,000 |
| Bernard Zovighian | Dec 10, 2025 | Sell | 3,863 | $83.45 | $320,000 |
| Scott Ullem | Dec 9, 2025 | Sell | 7,700 | $84.47 | $650,000 |
| Bernard Zovighian | Dec 8, 2025 | Sell | 21,487 | $85.21 | $1.8M |
| Wayne Markowitz | Dec 8, 2025 | Sell | 583 | $86.01 | $50,000 |
| Scott Ullem | Nov 10, 2025 | Sell | 10,026 | $83.02 | $830,000 |
| Scott Ullem | Nov 10, 2025 | Sell | 2,974 | $83.3 | $250,000 |
| Daniel Lippis | Nov 10, 2025 | Sell | 1,020 | $82.55 | $84,000 |
| Daveen Chopra | Aug 25, 2025 | Sell | 2,500 | $81.95 | $200,000 |
| Larry Wood | Aug 18, 2025 | Sell | 8,950 | $78.06 | $700,000 |
| Daniel Lippis | Jul 28, 2025 | Sell | 4,114 | $79.46 | $330,000 |
| Larry Wood | Jun 16, 2025 | Sell | 8,950 | $75.23 | $670,000 |
| Bernard Zovighian | Jun 3, 2025 | Sell | 967 | $77.32 | $75,000 |
| BOBO DONALD E JR | Jun 2, 2025 | Sell | 2,570 | $77.4 | $200,000 |
| Bernard Zovighian | May 30, 2025 | Sell | 16,099 | $77.21 | $1.2M |
| Daveen Chopra | May 22, 2025 | Sell | 1,500 | $75.08 | $110,000 |
| Scott Ullem | May 9, 2025 | Sell | 11,250 | $74.4 | $840,000 |
| Daniel Lippis | May 9, 2025 | Sell | 330 | $74.42 | $25,000 |
| Wayne Markowitz | May 7, 2025 | Sell | 268 | $75.08 | $20,000 |
| Bernard Zovighian | May 5, 2025 | Sell | 5,980 | $74.91 | $450,000 |
| BOBO DONALD E JR | Apr 14, 2025 | Sell | 9,500 | $69.81 | $660,000 |
| Daniel Lippis | Apr 8, 2025 | Sell | 300 | $70.61 | $21,000 |
| Scott Ullem | Mar 26, 2025 | Sell | 11,250 | $70.87 | $800,000 |
| BOBO DONALD E JR | Mar 13, 2025 | Sell | 9,500 | $67.96 | $650,000 |
| Bernard Zovighian | Mar 10, 2025 | Sell | 6,164 | $69.51 | $430,000 |
| Daniel Lippis | Mar 10, 2025 | Sell | 400 | $69.48 | $28,000 |
| Scott Ullem | Feb 28, 2025 | Sell | 7,760 | $70.52 | $550,000 |
| Scott Ullem | Feb 28, 2025 | Sell | 3,490 | $71.38 | $250,000 |
| STEVEN LORANGER | Feb 14, 2025 | Sell | 5,739 | $76.42 | $440,000 |
| Scott Ullem | Feb 13, 2025 | Sell | 11,250 | $75.76 | $850,000 |
| BOBO DONALD E JR | Feb 13, 2025 | Sell | 6,400 | $75.74 | $480,000 |
| STONE HEISZ LESLIE | Feb 13, 2025 | Sell | 5,739 | $75.86 | $440,000 |
| BOBO DONALD E JR | Feb 13, 2025 | Sell | 100 | $76.26 | $7,600 |
| Daniel Lippis | Feb 13, 2025 | Sell | 500 | $76.34 | $38,000 |
| BOBO DONALD E JR | Jan 16, 2025 | Sell | 5,000 | $68.75 | $340,000 |
| Daniel Lippis | Jan 16, 2025 | Sell | 500 | $68.76 | $34,000 |
| Daniel Lippis | Dec 16, 2024 | Sell | 2,500 | $74.08 | $190,000 |
| Scott Ullem | Dec 9, 2024 | Sell | 11,250 | $71.68 | $810,000 |
| BOBO DONALD E JR | Dec 9, 2024 | Sell | 5,000 | $71.75 | $360,000 |
| Daveen Chopra | Dec 6, 2024 | Sell | 1,750 | $73.27 | $130,000 |
| Wayne Markowitz | Dec 6, 2024 | Sell | 583 | $73.27 | $43,000 |
| BOBO DONALD E JR | Nov 13, 2024 | Sell | 5,000 | $65.57 | $330,000 |
| Larry Wood | Nov 5, 2024 | Sell | 25,000 | $65.91 | $1.6M |
Frequently Asked Questions: Edwards Lifesciences Insider Trading
In the past 90 days, Edwards Lifesciences insiders have made 0 buys and 11 sells. The net selling may indicate insiders are taking profits or reducing exposure.
The most recent sale was by Daniel Lippis who sold 619 shares on October 8, 2026. View all transactions in the table on this page.
Insider buying is generally a stronger signal than insider selling, since insiders may sell for personal reasons (diversification, taxes) but typically buy only when they believe the stock is undervalued. AltIndex uses insider transaction patterns alongside 25+ other signals in the AI Score.
BOBO DONALD E JR has sold the most EW stock in the last 2 years, with a total value of $14M.
The total value of insider transactions for Edwards Lifesciences in the last 2 years is negative, amounting to -$42M. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
